Solid Biosciences Inc. SLDB Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Research And Development Expense by Product | ||||||
| Internal Research And Development Expense | $9.15M+11.6% | $8.2M+8.9% | $7.53M+11.3% | $6.77M-1.1% | $6.84M+12.4% | |
| SGT003 | $22.94M+20.7% | $19M+5.8% | $17.95M+46.9% | $12.22M+33.3% | $9.17M+63.2% | |
| SGT501 | $1.41M-2.9% | $1.45M-3.6% | $1.5M-32.4% | $2.22M-50.2% | $4.47M-33.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Solid Biosciences Inc. break its business down?
- Solid Biosciences Inc. (SLDB) reports research and development expense by product across 4 parts — External General And Administrative Expense, Internal Research And Development Expense, SGT003 and SGT501. Each is extracted from the segment footnotes and tracked over time.
- Where does Solid Biosciences Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Solid Biosciences Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
